Skandinaviska Enskilda Banken AB publ Raises Stock Holdings in DuPont de Nemours, Inc. $DD

Skandinaviska Enskilda Banken AB publ grew its stake in shares of DuPont de Nemours, Inc. (NYSE:DD) by 1,135.4% during the third quarter, Holdings Channel reports. The institutional investor owned 1,159,785 shares of the basic materials company’s stock after buying an additional 1,065,905 shares during the period. Skandinaviska Enskilda Banken AB publ’s holdings in DuPont de Nemours were worth $90,347,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in DuPont de Nemours during the 2nd quarter worth approximately $313,306,000. Vanguard Group Inc. boosted its position in shares of DuPont de Nemours by 6.7% in the third quarter. Vanguard Group Inc. now owns 50,867,267 shares of the basic materials company’s stock worth $3,962,560,000 after purchasing an additional 3,203,044 shares during the period. Ilex Capital Partners UK LLP increased its stake in shares of DuPont de Nemours by 175.8% in the second quarter. Ilex Capital Partners UK LLP now owns 2,043,299 shares of the basic materials company’s stock worth $140,150,000 after purchasing an additional 1,302,341 shares in the last quarter. AQR Capital Management LLC raised its position in shares of DuPont de Nemours by 139.3% during the 2nd quarter. AQR Capital Management LLC now owns 1,791,511 shares of the basic materials company’s stock valued at $122,486,000 after purchasing an additional 1,042,929 shares during the period. Finally, Holocene Advisors LP raised its position in shares of DuPont de Nemours by 70.5% during the 2nd quarter. Holocene Advisors LP now owns 2,398,287 shares of the basic materials company’s stock valued at $164,499,000 after purchasing an additional 991,985 shares during the period. 73.96% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

DD has been the subject of several recent analyst reports. Citigroup upped their target price on shares of DuPont de Nemours from $50.00 to $59.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. Wolfe Research boosted their price objective on DuPont de Nemours from $49.00 to $54.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. JPMorgan Chase & Co. increased their target price on DuPont de Nemours from $48.00 to $50.00 and gave the stock an “overweight” rating in a research report on Friday, January 16th. Morgan Stanley decreased their target price on DuPont de Nemours from $80.00 to $44.00 in a research note on Monday, November 10th. Finally, KeyCorp upped their price target on DuPont de Nemours from $51.00 to $57.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $50.46.

Insider Buying and Selling at DuPont de Nemours

In other DuPont de Nemours news, CEO Lori Koch sold 9,011 shares of DuPont de Nemours stock in a transaction on Friday, November 28th. The shares were sold at an average price of $39.46, for a total value of $355,574.06. Following the completion of the transaction, the chief executive officer directly owned 288,326 shares of the company’s stock, valued at $11,377,343.96. This trade represents a 3.03% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Erik T. Hoover sold 6,005 shares of the business’s stock in a transaction dated Friday, November 28th. The stock was sold at an average price of $39.79, for a total transaction of $238,938.95. Following the completion of the sale, the senior vice president owned 112,101 shares in the company, valued at approximately $4,460,498.79. This trade represents a 5.08% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.61% of the stock is owned by company insiders.

DuPont de Nemours Price Performance

NYSE:DD opened at $50.19 on Tuesday. The business’s 50-day moving average is $43.48 and its 200 day moving average is $37.44. DuPont de Nemours, Inc. has a 12 month low of $22.50 and a 12 month high of $52.66. The company has a market capitalization of $21.03 billion, a P/E ratio of -26.98, a P/E/G ratio of 1.26 and a beta of 1.10. The company has a current ratio of 2.42, a quick ratio of 1.91 and a debt-to-equity ratio of 0.22.

DuPont de Nemours (NYSE:DD) last issued its quarterly earnings data on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.03. The business had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.69 billion. DuPont de Nemours had a positive return on equity of 7.37% and a negative net margin of 7.03%.The company’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.13 EPS. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. On average, equities research analysts forecast that DuPont de Nemours, Inc. will post 4.38 earnings per share for the current fiscal year.

DuPont de Nemours announced that its board has authorized a stock buyback plan on Thursday, November 6th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the basic materials company to reacquire up to 12.2% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

DuPont de Nemours Profile

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.